Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats

Life Sciences

Volumn 83, Issue 15-16, 2008, Pages 563-568

  Othman, Azza I ^a   El Missiry, Mohammed A ^a   Amer, Maher A ^a   Arafa, Magada ^a  

^a Mansoura University   (Egypt)

Author keywords

Adriamycin; Antioxidants; Ferritin; Heart; Iron; Iron binding proteins; Liver; Melatonin; Oxidative stress; Transferritin

Indexed keywords

AMINOTRANSFERASE; CATALASE; CREATINE KINASE; DOXORUBICIN; FERRITIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IRON; LACTATE DEHYDROGENASE; MELATONIN; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; DOXORUBICIN; FERRITINS; FREE RADICALS; HEART; IRON; LIVER; LIVER FUNCTION TESTS; MALE; MELATONIN; OXIDANTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; TRACE ELEMENTS; TRANSFERRIN;

RATTUS;

EID: 52149096467     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.08.004     Document Type: Article

References (64)

1. Abd El-Aziz M.A., Othman A.I., Amer M., and El-Missiry M.A. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. Journal of Applied Toxicology 21 6 (2001) 469-473
2. Ayaki H., Lee M.J., Sumino K., and Nishio H. Different cytoprotective effect of antioxidants and change in the iron regulatory system in rodent cells exposed to paraquat or formaldehyde. Toxicology 208 (2005) 73-79
3. Red cell metabolism. In: Beutler E. (Ed). A Manual of Biochemical Methods (1975), Grune and Stratton, New York 67-69
4. Blatt J., and Huntley D. Enhancement of in vitro activity against neuroblastoma by doxorubicin and deferoxamine. Journal of National Cancer Institute 81 (1989) 866-870
5. Bock P.P., Kramer R., and Pravelka M. A simple assay for catalase determination. Cell Biology Monographs 7 (1980) 44-74
6. Cairo G., Tacchini L., Pogliaghi G., Anzon E., Tomasi A., and Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and posttranscriptional regulation by expansion of the "free" iron pool. Journal of Biological Chemistry 270 (1995) 700-703
7. Cos S., and Sanchez-Barcelo E.J. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Letter 9 (1995) 207-212
8. Deepa P.R., and Varalakshmi P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chemico-Biological Interactions 146 (2003) 201-210
9. Deman A., Ceyssens B., Pauwels M., Zhang J., Houte K.V., Verbeelen D., and Van den Branden C. Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Nephrology Dialysis Transplantation 16 (2001) 147-150
10. Demant E.J.F. Transfer of ferritin-bound iron to adriamycin. Federation of Biochemical Societies 176 1 (1984) 97-100
11. El-Missiry M.A. Prophylactic effect of melatonin on lead-induced inhibition of heme biosynthesis and deterioration of antioxidant systems in male rats. Journal of Biochemical and Molecular Toxicology 14 (2000) 57-62
12. El-Missiry M.A., and Abd El-Aziz A.F. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Letter 151 (2000) 119-125
13. El-Missiry M.A., Othman A.I., Amer M.A., and Abd El-Aziz M.A. Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-ercaptopropionyl) glycine in rats. Free Radical Research 35 5 (2001) 575-581
14. El-Missiry M.A., Fayed T.A., El-Sawy M.R., and El-Sayed A.A. Amelioration effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury. Ecotoxicology and Environmental Safety 66 (2007) 278-286
15. El-sokkary G.H., Kamel E.S., and Reiter R.J. Prophylactic effect of melatonin in reducing lead induced neurotoxicity in the rat. Cellular & Molecular Biology Letters 8 (2003) 461-470
16. El-Sokkary G.H., Abdel-Rahman G.H., and Kamel E.S. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 213 (2005) 25-33
17. Fadillioglu E., Oztas E., Erdogan H., Yagmurca M., Sogut S., Ucar M., and Irmak M.K. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. Journal of Applied Toxicology 24 (2004) 47-52
18. Gianni L., and Myers C. In: Muggia F.M., Green M.D., and Speyer J.L. (Eds). The role of free radical formation in the cardiotoxicityof anthracycline in cancer treatment and the heart (1992), Johns Hopkins University Press, Baltimore 9-46
19. Graham R.M., Reutens G.M., Herbison C.E., Delima R.D., Chua1 A.C., Olynyk J.K., and Trinder D. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. Journal of Hepatology 48 (2008) 327-334
20. Grootveld M., Bell J.D., Halliwell B., Aruoma O.I., Bomford A., and Sadler P.J. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. Journal of Biological Chemistry 264 (1989) 4417-4422
21. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione-S-transferase the first enzyme step in mercapturic acid formation. Journal of Biological Chemistry 249 (1974) 7130-7139
22. Hershko C., Link G., Tzahor M., Kaltwasser J.P., Athias P., Grynberg A., and Pinson A. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. Journal of Laboratory and Clinical Medicine 122 (1993) 245-251
23. Iwasaki K., Mackenzie E.L., Hailemariam K., Sakamoto K., and Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Molecular and Cellular Biology 26 (2006) 2845-2856
24. Julicher R.H., Sterrenberg L., Haenen G.R., Bast A., and Noordhoek J. The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat. Archives of Toxicology 61 (1988) 275-281
25. Kang J., Lee Y., No K., Jung E., Sung J., Kim Y., and Nam S. Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis. Reproductive Toxicology 16 (2002) 291-298
26. Kwok J.C., and Richardson D.R. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway. Molecular Pharmacology 63 (2003) 849-861
27. Lee Y.M., Chen H.R., Hsiao G., Shen J.R., Wang J.J., and Yen N.H. Protection effects of melatonin on myocardial ischemia/reperfusion injury in vivo. Journal of Pineal Research 33 (2002) 72-80
28. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods of Enzymology 186 (1990) 464-478
29. Lim P.S., Wei Y.H., Yu Y.L., and Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrology Dialysis Transplantation 14 (1999) 2680-2687
30. Limson J., Nyokog T., and Daya S. The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. Journal of Pineal Research 24 1 (1998) 15-21
31. Link G., Tirosh R., Pinson A., and Hershko C. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. Journal of Laboratory and Clinical Medicine 127 (1996) 272-278
32. Maharaj D.S., Limson J.L., and Daya S. 6-Hydroxymelatonin converts Fe(III) to Fe(II) and reduces iron-induced lipid peroxidation. Life Science 12 (2003) 1367-1375
33. Menendez-Pelaez A., and Reiter R.J. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. Journal of Pineal Research 15 2 (1993) 59-69
34. Minotti G., Ronchi R., Salvatorelli E., Menna P., and Gaetano Cairo G. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Research 61 (2001) 8422-8428
35. Mueller S., Pantopoulos K., Christian A., Hübner C.A., Stremmel W., Matthias W., and Hentze M.W. IRP1 activation by extracellular oxidative stress in the perfused rat liver. Journal of Biological Chemistry 276 25 (2001) 23192-23196
36. Muraoka S., and Miura T. Free radicals mediate cardiac toxicity induced by adriamycin. Yakugaku Zasshi 123 (2003) 855-866
37. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Annals of Biochemistry 95 (1979) 351-358
38. Othman A.I., Al Sharawy S., and El-Missiry M.A. Role of melatonin in ameliorating lead induced haematotoxicity. Pharmacological Research 50 (2004) 301-307
39. Othman A.I., El-Missiry M.A., and Amer M.A. The protective action of melatonin on indomethacin-induced gastric and testicular oxidative stress in rats. Redox Report 6 3 (2001) 173-177
40. Outomuro D., Grana D.R., Azzato F., and Milei J. Adriamycin-induced myocardial toxicity: new solutions for an old problem. International Journal of Cardiology 117 1 (2007) 6-15
41. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70 (1967) 158-169
42. Prahalathan C., Selvakumar E., and Varalakshmi P. Lipoic acid modulates adriamycin-induced testicular toxicity. Reproductive Toxicology 21 (2006) 54-59
43. Radogna F., Paternoster L., Albertini M.C., Cerella C., Accorsi A., Bucchini A., Spadoni G., Diamantini G., Tarzia G., De Nicola M., D'Alessio M., and Ghibelli L. Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. Journal of Pineal Research 43 2 (2007) 154-162
44. Rao M.V., and Gangadharan B. Antioxidative potential of melatonin against mercury induced intoxication in spermatozoa in vitro. Toxicology in Vitro 22 (2008) 935-942
45. Reif D.W. Ferritin as a source of iron for oxidative damage. Free Radical Biology & Medicine 12 5 (1992) 417-427
46. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Progress in Neurobiology 56 (1998) 359-384
47. Reiter R.J. Oxidative damage to nuclear DNA: amelioration by melatonin. Neuroendocrinology Letters 20 (1999) 145-150
48. Reiter R.J., Acuna-Castroviejo D., Tan D.X., and Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Annals of the New York Academy of Sciences 939 (2001) 200-215
49. Reiter R.J., Cabrera J., Sainz R., Mayo J.C., Manchester L.C., and Tan D.X. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease, and Parkinsonism. Annals of the New York Academy of Sciences 890 (1999) 471-485
50. Reiter R.J., Tan D.X., Cabrera J., and D'Arpa D. Melatonin and tryptophan derivatives as free radical scavengers and antioxidants. Advances in Experimental Medicine and Biology 467 (1999) 379-387
51. Reiter R.J., Tan D., and Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mechanism of Ageing and Development 123 (2002) 1007-1019
52. Reiter R.J., Tan D.X., Gitto E., Sainz R.M., Mayo J.C., Leon J., Manchester L.C., Vijayalaxm, Kilic E., and Kilic U. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Polish Journal of Pharmacology 56 2 (2004) 159-170
53. Reiter R.J., Tan D.X., Qi W., Manchester L.C., Karbownik M., and Calvo J.R. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biological Signals and Receptors 9 (2000) 160-171
54. Richardson D.R., and Milnes K. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxyl-1-napthylaldehyde benzoyl hydrazone. Blood 89 (1997) 3025-3038
55. Sener G., Jahovic N., Tosun O., Atasoy B.M., and Yegen B. Melatonin meliorates ionizing radiation-induced oxidative organ damage in rats. Life Science 74 (2003) 563-572
56. Singal P.K., Li T., Kumar D., Danelisen I., and Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Molecular and Cellular Biochemistry 207 (2000) 77-86
57. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34 (1988) 497-500
58. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., and Reiter R.J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal 1 (1993) 57-60
59. Tan D.X., Reiter R.J., Manchester L.C., Yan M.T., El-sawi M., Sainz R.M., Mayo J.C., Kohen R., Allegra M., and Hardeland R. Chemical and physical properties of potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Current Topics in Medicinal Chemistry 2 (2002) 181-198
60. Tanaka Y., and Takahashi K. Cardiac oxygen radical metabolism in adriamycin-induced cardiotoxicity. Jikeikai Medical Journal 37 (1990) 253-264
61. Theil E.C., Matzapetakis M., and Liu X. Ferritins: iron/oxygen biominerals in protein nanocages. Journal of Biological Inorganic Chemistry 11 (2006) 803-810
62. Venditti P., Balestrieri M., De Le T., and Di Meo S. Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibers. Cardiovascular Research 38 (1998) 695-702
63. Vijayalaxmi Jr. C.R.T., Reiter R.J., Tan D.X., Herman T.S., and Thomas Jr. C.R. Melatonin as a radioprotective agent: a review. International Journal of Radiation Oncology, Biology, Physics 59 (2004) 639-653
64. Yilmaz S., Atessahin A., Sahna E., Karahan I., and Songul O. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218 (2006) 164-171